Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate

NDT Plus

Volumn 1, Issue 3, 2008, Pages 196-

  Lindley, Elizabeth ^a   Tattersall, James ^a   Wright, Mark ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; LANTHANUM CARBONATE; PHOSPHATE; SEVELAMER;

ADULT; AGED; BICARBONATE BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG PREFERENCE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCALCEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; OBSERVATIONAL STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RENAL REPLACEMENT THERAPY;

EID: 44449122816     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn034     Document Type: Letter

References (2)

1. Sonikian MA, Pani IT, Iliopoulos AN et al. Metabolic acidosis aggravation and hyperkalemia in hemodialysis patients treated by sevelamer hydrochloride. Ren Fail 2005; 27: 143-147
2. Oka Y, Miyazaki M, Takatsu S et al. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage. Ther Apher Dial 2007; 11: 107-113